6/10
08:49 am
opk
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients [Yahoo! Finance]
Low
Report
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients [Yahoo! Finance]
6/6
01:04 pm
opk
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report? [Yahoo! Finance]
Medium
Report
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report? [Yahoo! Finance]
6/5
07:08 am
opk
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients [Yahoo! Finance]
Low
Report
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients [Yahoo! Finance]
6/4
01:13 am
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
6/1
10:15 am
opk
Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock [Yahoo! Finance]
Neutral
Report
Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock [Yahoo! Finance]
5/31
10:48 am
opk
OPKO Health to Participate in the Jefferies Global Healthcare Conference
Low
Report
OPKO Health to Participate in the Jefferies Global Healthcare Conference
5/25
12:06 am
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
5/23
08:15 am
opk
Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors [Yahoo! Finance]
Medium
Report
Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors [Yahoo! Finance]
5/22
04:17 pm
opk
GeneDx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
GeneDx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
5/17
12:03 am
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.
5/13
08:09 am
opk
Komodo Grows Its MapEnhance Offering, Expanding Access to New Social Determinants of Health Insights Alongside Real-World Oncology Data and Rare Disease Genomics [Yahoo! Finance]
Low
Report
Komodo Grows Its MapEnhance Offering, Expanding Access to New Social Determinants of Health Insights Alongside Real-World Oncology Data and Rare Disease Genomics [Yahoo! Finance]
5/10
04:23 pm
opk
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Low
Report
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
5/9
10:42 am
opk
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y [Yahoo! Finance]
Low
Report
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y [Yahoo! Finance]
5/8
11:58 am
opk
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
10:09 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Medium
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
5/7
10:16 pm
opk
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Medium
Report
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
5/7
09:21 pm
opk
Opko Health (OPK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Opko Health (OPK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
04:19 pm
opk
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results [Yahoo! Finance]
Low
Report
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results [Yahoo! Finance]
5/7
04:05 pm
opk
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
Low
Report
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
5/3
08:00 am
opk
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
Low
Report
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
4/29
04:24 pm
opk
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Medium
Report
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
4/23
08:47 am
opk
GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset [Yahoo! Finance]
Low
Report
GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset [Yahoo! Finance]
4/4
04:16 pm
opk
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 [Yahoo! Finance]
Low
Report
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 [Yahoo! Finance]
4/3
08:08 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
4/1
02:42 pm
opk
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp [Yahoo! Finance]
Low
Report
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp [Yahoo! Finance]